Stocktoria

Arcus Biosciences, Inc. RCUS

NYSE · stock · Pharmaceutical Preparations · website · IPO 2018-03-15

Arcus Biosciences, Inc. statistics & valuation

Market cap$3.9B
P / S15.8×
P / B6.2×
Net margin-142.9%
Return on equity-55.9%
FCF margin-196.0%
Net cash$123.0M
Enterprise value USD$3.8B
Earnings yield EBIT/EV-10.2%
Return on capital-42.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-3756.70% -593.70% -564.70% -157.70% 13.80% -238.40% -262.40% -109.70% -142.90% 201720182019202020212022202320242025
Gross margin (%)
201720182019202020212022202320242025
Operating margin (%)
-3782.10% -656.80% -591.40% -159.00% 14.10% -250.00% -290.60% -127.90% -156.30% 201720182019202020212022202320242025
Return on equity (%)
-21.10% -51.70% -24.50% 6.30% -40.60% -66.50% -58.40% -55.90% 201720182019202020212022202320242025
Shares outstanding
4.1M 44.5M 45.9M 65.1M 74.0M 72.9M 75.5M 92.2M 125.3M 201720182019202020212022202320242025
Net debt ($)
-$127.0M -$102.0M -$123.0M 201720182019202020212022202320242025
Share buybacks ($)
201720182019202020212022202320242025
Return on assets (%)
-27.90% -18.00% -41.70% -15.90% 3.30% -19.90% -28.00% -24.60% -31.00% 201720182019202020212022202320242025
Free cash flow margin (%)
-2163.70% -559.50% -502.60% 138.50% -73.60% 385.70% -282.10% -68.20% -196.00% 201720182019202020212022202320242025
Debt / equity (×)
0.00× 0.10× 0.16× 201720182019202020212022202320242025
EPS ($)
-$1.93 -$2.24 $0.71 -$3.71 -$4.15 -$3.14 -$3.29 201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin-156.3%-127.9%-290.6%-250.0%14.1%-159.0%-591.4%-656.8%-3782.1%
Net margin-142.9%-109.7%-262.4%-238.4%13.8%-157.7%-564.7%-593.7%-3756.7%
FCF margin-196.0%-68.2%-282.1%385.7%-73.6%138.5%-502.6%-559.5%-2163.7%
Return on assets-31.0%-24.6%-28.0%-19.9%3.3%-15.9%-41.7%-18.0%-27.9%
Return on equity-55.9%-58.4%-66.5%-40.6%6.3%-24.5%-51.7%-21.1%73.4%
Debt / equity0.16×0.10×0.00×——————
Current ratio4.364.504.525.537.606.058.4915.2913.90

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.